This retrospective study analyzes variation in prostate-specific antig
en (PSA) levels in 1 29 males who were not diagnosed with prostate can
cer or other known malignancies. The extent to which the assay and the
biologic variation contributed to the variation in PSA concentration
was evaluated from analysis of slopes characterizing PSA concentration
as a function of time. The mean coefficient of variation on observati
ons was 58.0 percent. The estimated mean biologic coefficient of varia
tion was 55.3 percent versus a mean assay coefficient of variation of
13.2 percent, indicating that the assay variation contributed negligib
ly to variation compared with the biologic variation. The concept that
a PSA level which rises more than that attributable to assay variatio
n indicates the need for invasive testing for prostate cancer is quest
ionable. A decreasing PSA level was seen as often and of the same magn
itude as an increasing level within a relatively narrow window of appr
oximately one year. We are aware of no reason why this variability in
PSA values would not be observed in patients with occult prostate canc
er.